HomeZVSA • NASDAQ
add
ZyVersa Therapeutics Ord Shs
Previous close
$6.00
Day range
$4.44 - $6.20
Year range
$4.44 - $220.63
Market cap
37.82M USD
Avg Volume
58.61K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.78M | -65.75% |
Net income | -13.34M | -185.18% |
Net profit margin | — | — |
Earnings per share | -1.04K | — |
EBITDA | -1.77M | 65.78% |
Effective tax rate | 4.28% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.14M | -46.84% |
Total assets | 22.11M | -81.34% |
Total liabilities | 11.04M | -41.41% |
Total equity | 11.07M | — |
Shares outstanding | 7.59M | — |
Price to book | 2.20 | — |
Return on assets | -16.16% | — |
Return on capital | -28.81% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.34M | -185.18% |
Cash from operations | -2.79M | 26.84% |
Cash from investing | — | — |
Cash from financing | 4.35M | 747.43% |
Net change in cash | 1.56M | 147.28% |
Free cash flow | -2.20M | 41.91% |
About
Founded
2021
Headquarters
Website
Employees
7